Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study.

Jingmin ZhouYamei XuZhaofen ZhengShuyang ZhangJiefu YangYuhui ZhangBaopeng TangHuiyuan HanQing ZhangFan LiuWenhui DingCaizhen QianGuohai SuXiaohui LiuYuansheng ShenBei ShiXiangqing KongZhiming GePing ZhangXiaomei GuoHong ZhangYuemin SunYugang DongGuosheng FuLei FengJun-Bo Genull null

Published in: ESC heart failure (2024)

Ivabradine treatment reduced HR and improved cardiac function and health-related quality of life in Chinese patients with chronic HF. Benefits were seen irrespective of whether or not patients were also taking ARNIs or beta-blockers. Treatment was well tolerated with a similar profile to previous ivabradine studies.

Keyphrases

ejection fraction
heart rate
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
heart failure
blood pressure
combination therapy
patient reported outcomes